Press releases

Anne Dupraz-Poiseau, Ph.D. as Orchard's new Chief Regulatory Affairs Officer

Orchard Therapeutics Limited announces the appointment of Anne Dupraz-Poiseau, Ph.D. as Chief Regulatory Affairs Officer

Read more

Orchard hopes to bear the fruit of gene therapy

Daniel Levine from Global Gene RARE Cast spoke to Andrea Spezzi, Chief Medical Officer for Orchard about the company, its approach to gene therapy, and how its addressing the challenges of bringing such treatments to market

Read more

Orchard Therapeutics launches and announces academic partnerships for development of transformative gene therapies

Orchard Therapeutics has officially launched today with a £21 million Series A financing led by F-Prime Capital

Read more